Cliff Asness's GSK Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 236,602 shares of GSK plc (GSK) worth $11.6 M, representing 0.01% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Cliff Asness has maintained this position in GSK for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 150,316 shares. Largest reduction occurred in Q4 2024, reducing 5,636 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's GSK plc (GSK) Holding Value Over Time
Track share changes against reported price movement
Quarterly GSK plc (GSK) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +32,996 | Add 16.21% | 236,602 | $49.04 |
| Q3 2025 | +150,316 | Add 282.07% | 203,606 | $43.16 |
| Q2 2025 | +13,051 | Add 32.43% | 53,290 | $38.40 |
| Q1 2025 | +18,420 | Add 84.42% | 40,239 | $38.74 |
| Q4 2024 | -5,636 | Reduce 20.53% | 21,819 | $33.82 |
| Q3 2024 | +1,092 | Add 4.14% | 27,455 | $40.88 |
| Q2 2024 | +13,403 | Add 103.42% | 26,363 | $38.50 |
| Q1 2024 | +12,960 | New Buy | 12,960 | $42.87 |
Cliff Asness's GSK plc Investment FAQs
Cliff Asness first purchased GSK plc (GSK) in Q1 2024, acquiring 12,960 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held GSK plc (GSK) for 8 quarters since Q1 2024.
Cliff Asness's largest addition to GSK plc (GSK) was in Q3 2025, adding 203,606 shares worth $8.79 M.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 236,602 shares of GSK plc (GSK), valued at approximately $11.6 M.
As of the Q4 2025 filing, GSK plc (GSK) represents approximately 0.01% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in GSK plc (GSK) was 236,602 shares, as reported at the end of Q4 2025.